Compare FIHL & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FIHL | PRGO |
|---|---|---|
| Founded | 2014 | 1887 |
| Country | Bermuda | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2015 | 2013 |
| Metric | FIHL | PRGO |
|---|---|---|
| Price | $18.53 | $10.82 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $22.36 | $19.33 |
| AVG Volume (30 Days) | 437.7K | ★ 2.8M |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | 3.16% | ★ 10.36% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | $16.34 | $0.02 |
| Revenue Next Year | $7.05 | $1.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.39 | $11.13 |
| 52 Week High | $20.50 | $29.08 |
| Indicator | FIHL | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 39.09 | 22.11 |
| Support Level | $18.56 | N/A |
| Resistance Level | $19.05 | $15.08 |
| Average True Range (ATR) | 0.53 | 0.60 |
| MACD | -0.13 | -0.41 |
| Stochastic Oscillator | 21.93 | 2.84 |
Fidelis Insurance Holdings Ltd is a specialty insurer that leverages strategic partnerships to offer tailored insurance solutions. The company classifies its business into two segments, Insurance and Reinsurance. A majority of its revenue is generated from the Insurance segment, which comprises a portfolio of property, marine, aviation and aerospace, political risk, violence and terror, energy, cyber, and other insurance risks. The Reinsurance segment consists of an actively managed property reinsurance book, providing reinsurance and a limited amount of retrocession coverage across the world on a proportional or excess-of-loss basis. Geographically, the company derives its key revenue from the United Kingdom, followed by Bermuda and the Republic of Ireland.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.